EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Mortality and Cancer in Offspring of Mothers With Biopsy‐Proven MASLD During Pregnancy: A Nationwide Cohort Study

Carole A Marxer iD, Fahim Ebrahimi, David Bergman, Jiangwei Sun, Hannes Hagström iD, Marcus Thuresson, Olof Stephansson, Jonas F Ludvigsson

Liver International · 2025-07 · 45 (7)

DOI: 10.1111/liv.70174 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Liver International, online erschienen am 11.06.2025. Verfasst von Carole A Marxer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Neoplasms, Prenatal Exposure Delayed Effects, Fatty Liver, Pregnancy Complications. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, European Crohn's and Colitis Organisation and the Swedish Society for Medical Research, Karolinska Institutet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Health‐related outcomes through early adulthood among offspring prenatally exposed to maternal metabolic dysfunction‐associated steatotic liver disease (MASLD) are insufficiently investigated. We aimed to study the risk of mortality and cancer in such offspring.

Methods

This nationwide cohort study included all singleton live born offspring with prenatal exposure to maternal biopsy‐proven MASLD (1992–2017; N = 239) in Sweden. MASLD offspring were matched with up to five reference offspring ( N = 1131) of mothers without known MASLD by maternal age at delivery, calendar year of delivery, and parity. We used a multivariable Cox proportional hazard model to calculate adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs) for mortality and cancer up until 31 December 2021. For mortality, we stratified by maternal MASLD severity (simple steatosis alone vs. severe MASLD comprising steatohepatitis, liver fibrosis or cirrhosis).

Results

Over a median follow‐up of 16.9 years, two deaths occurred in offspring prenatally exposed to maternal MASLD (IR 0.5/1000 person‐years, 95% CI 0.1–1.8) and seven deaths in reference offspring (IR 0.4/1000 person‐years, 95% CI 0.1–0.8), which corresponded to an aHR of 1.78 (95% CI 0.27–11.97). Higher disease severity was not associated with an increased risk of death. We observed few cancer events with similar IR/1000 person‐years (0.2 [95% CI 0.0–1.4] vs. 0.3 [0.1–0.6] in reference offspring), which corresponded to an aHR of 0.64 (95% CI 0.07–5.95).

Conclusions

We found no evidence that prenatal exposure to maternal MASLD affects the risk of death or cancer through early adulthood but larger studies are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPrenatal Exposure Delayed EffectsFatty LiverPregnancy ComplicationsHumansFemalePregnancySwedenAdultMaleCohort StudiesProportional Hazards ModelsRisk FactorsBiopsy

Stichwörter der Autor:innen

MASLDNAFLDcancerepidemiologymortalitypaediatrics

Autor:innen und Institutionen

  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Department of Gastroenterology and Hepatology, University Digestive Health Care Center Basel - Clarunis, Basel, Switzerland.
  • Division of Hepatology, Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Statisticon AB, Uppsala, Sweden.
  • Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Carole A Marxer, Hannes Hagström

Förderung

  • Swiss National Science Foundation
  • European Crohn's and Colitis Organisation and the Swedish Society for Medical Research
  • Karolinska Institutet
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Marxer, C. A., Ebrahimi, F., Bergman, D., Sun, J., Hagström, H., Thuresson, M., Stephansson, O., & Ludvigsson, J. F. (2025). Mortality and Cancer in Offspring of Mothers With Biopsy‐Proven MASLD During Pregnancy: A Nationwide Cohort Study. Liver International, 45(7). https://doi.org/10.1111/liv.70174

Vancouver

Marxer CA, Ebrahimi F, Bergman D, Sun J, Hagström H, Thuresson M, et al. Mortality and Cancer in Offspring of Mothers With Biopsy‐Proven MASLD During Pregnancy: A Nationwide Cohort Study. Liver International. 2025;45(7). doi:10.1111/liv.70174

BibTeX
@article{Marxer2025,
  author = {Marxer, Carole A and Ebrahimi, Fahim and Bergman, David and Sun, Jiangwei and Hagström, Hannes and Thuresson, Marcus and Stephansson, Olof and Ludvigsson, Jonas F},
  title = {Mortality and Cancer in Offspring of Mothers With Biopsy‐Proven MASLD During Pregnancy: A Nationwide Cohort Study},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {7},
  doi = {10.1111/liv.70174}
}
Kostenlos starten →